27123473|t|New susceptible variant of COQ2 gene in Japanese patients with sporadic multiple system atrophy.
27123473|a|OBJECTIVE: The aim of this study was to analyze the association between the variations of coenzyme Q2 4-hydroxybenzoate polyprenyltransferase gene (COQ2) and Japanese patients with multiple system atrophy (MSA). METHODS: We investigated the genetic variations in exons 1, 2, 6, and 7 of the COQ2 gene in 133 Japanese patients with MSA and 200 controls and analyzed the association between the variations and MSA. RESULTS: Six DNA variations (G21S, L25V, V66L, P157S, V393A, and X422K) were found in the 133 patients with MSA, and G21S and X422K were new variations that had never been reported. V66L was a common variation that was found in all 133 patients with MSA. G21S, P157S, V393A, and X422K did not show gene frequency differences between patients with MSA and controls. On the other hand, L25V was newly proven to be the only risk factor of sporadic MSA with predominant olivopontocerebellar ataxia. CONCLUSIONS: The present study suggests L25V variant of COQ2 gene as a genetic risk factor in Japanese patients with MSA with cerebellar ataxia.
27123473	49	57	patients	Species	9606
27123473	63	95	sporadic multiple system atrophy	Disease	MESH:D019578
27123473	187	238	coenzyme Q2 4-hydroxybenzoate polyprenyltransferase	Gene	27235
27123473	264	272	patients	Species	9606
27123473	278	301	multiple system atrophy	Disease	MESH:D019578
27123473	303	306	MSA	Disease	MESH:D019578
27123473	414	422	patients	Species	9606
27123473	428	431	MSA	Disease	MESH:D019578
27123473	505	508	MSA	Disease	MESH:D019578
27123473	539	543	G21S	ProteinMutation	tmVar:p|SUB|G|21|S;HGVS:p.G21S;VariantGroup:3;CorrespondingGene:27235;RS#:766552045;CorrespondingSpecies:9606
27123473	545	549	L25V	ProteinMutation	tmVar:p|SUB|L|25|V;HGVS:p.L25V;VariantGroup:0;CorrespondingGene:27235;RS#:150145464;CorrespondingSpecies:9606
27123473	551	555	V66L	ProteinMutation	tmVar:p|SUB|V|66|L;HGVS:p.V66L;VariantGroup:1;CorrespondingGene:27235;RS#:6818847;CorrespondingSpecies:9606;CA#:288762
27123473	557	562	P157S	ProteinMutation	tmVar:p|SUB|P|157|S;HGVS:p.P157S;VariantGroup:4;CorrespondingGene:27235;RS#:1462568548;CorrespondingSpecies:9606
27123473	564	569	V393A	ProteinMutation	tmVar:p|SUB|V|393|A;HGVS:p.V393A;VariantGroup:2;CorrespondingGene:27235;RS#:148156462;CorrespondingSpecies:9606;CA#:323452
27123473	575	580	X422K	ProteinMutation	tmVar:p|SUB|X|422|K;HGVS:p.X422K;VariantGroup:5;CorrespondingGene:27235;CorrespondingSpecies:9606
27123473	604	612	patients	Species	9606
27123473	618	621	MSA	Disease	MESH:D019578
27123473	627	631	G21S	ProteinMutation	tmVar:p|SUB|G|21|S;HGVS:p.G21S;VariantGroup:3;CorrespondingGene:27235;RS#:766552045;CorrespondingSpecies:9606
27123473	636	641	X422K	ProteinMutation	tmVar:p|SUB|X|422|K;HGVS:p.X422K;VariantGroup:5;CorrespondingGene:27235;CorrespondingSpecies:9606
27123473	692	696	V66L	ProteinMutation	tmVar:p|SUB|V|66|L;HGVS:p.V66L;VariantGroup:1;CorrespondingGene:27235;RS#:6818847;CorrespondingSpecies:9606;CA#:288762
27123473	746	754	patients	Species	9606
27123473	760	763	MSA	Disease	MESH:D019578
27123473	765	769	G21S	ProteinMutation	tmVar:p|SUB|G|21|S;HGVS:p.G21S;VariantGroup:3;CorrespondingGene:27235;RS#:766552045;CorrespondingSpecies:9606
27123473	771	776	P157S	ProteinMutation	tmVar:p|SUB|P|157|S;HGVS:p.P157S;VariantGroup:4;CorrespondingGene:27235;RS#:1462568548;CorrespondingSpecies:9606
27123473	778	783	V393A	ProteinMutation	tmVar:p|SUB|V|393|A;HGVS:p.V393A;VariantGroup:2;CorrespondingGene:27235;RS#:148156462;CorrespondingSpecies:9606;CA#:323452
27123473	789	794	X422K	ProteinMutation	tmVar:p|SUB|X|422|K;HGVS:p.X422K;VariantGroup:5;CorrespondingGene:27235;CorrespondingSpecies:9606
27123473	843	851	patients	Species	9606
27123473	857	860	MSA	Disease	MESH:D019578
27123473	894	898	L25V	ProteinMutation	tmVar:p|SUB|L|25|V;HGVS:p.L25V;VariantGroup:0;CorrespondingGene:27235;RS#:150145464;CorrespondingSpecies:9606
27123473	955	958	MSA	Disease	MESH:D019578
27123473	976	1003	olivopontocerebellar ataxia	Disease	MESH:D001259
27123473	1045	1049	L25V	ProteinMutation	tmVar:p|SUB|L|25|V;HGVS:p.L25V;VariantGroup:0;CorrespondingGene:27235;RS#:150145464;CorrespondingSpecies:9606
27123473	1108	1116	patients	Species	9606
27123473	1122	1125	MSA	Disease	MESH:D019578
27123473	1131	1148	cerebellar ataxia	Disease	MESH:D002524
27123473	Positive_Correlation	MESH:D002524	RS#:766552045;HGVS:p.G21S;CorrespondingGene:27235
27123473	Positive_Correlation	MESH:D001259	RS#:766552045;HGVS:p.G21S;CorrespondingGene:27235
27123473	Positive_Correlation	MESH:D001259	RS#:150145464;HGVS:p.L25V;CorrespondingGene:27235
27123473	Association	MESH:D019578	RS#:766552045;HGVS:p.G21S;CorrespondingGene:27235
27123473	Association	MESH:D019578	27235
27123473	Association	MESH:D019578	RS#:6818847;HGVS:p.V66L;CorrespondingGene:27235
27123473	Positive_Correlation	MESH:D019578	RS#:150145464;HGVS:p.L25V;CorrespondingGene:27235
27123473	Positive_Correlation	MESH:D001259	RS#:6818847;HGVS:p.V66L;CorrespondingGene:27235
27123473	Association	MESH:D019578	RS#:148156462;HGVS:p.V393A;CorrespondingGene:27235
27123473	Association	MESH:D019578	RS#:1462568548;HGVS:p.P157S;CorrespondingGene:27235
27123473	Positive_Correlation	MESH:D002524	RS#:150145464;HGVS:p.L25V;CorrespondingGene:27235
27123473	Association	MESH:D019578	HGVS:p.X422K;CorrespondingGene:27235
27123473	Association	MESH:D002524	27235
27123473	Association	MESH:D001259	27235
27123473	Association	MESH:D019578	27235

